QT
SAGE

Quantamental Technologies’s Sage Therapeutics SAGE Stock Holding History

Quantamental Technologies’s Portfolio SAGE Stock Details SAGE Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2023
Q2 		– Sell
-5,653
Closed -$237K – 626
2023
Q1 		$237K Buy
+5,653
New +$243K 0.13% 295
2020
Q4 		– Sell
-4,700
Closed -$287K – 245
2020
Q3 		$287K Sell
4,700
-700
-13% -$35.5K 0.21% 158
2020
Q2 		$225K Buy
+5,400
New +$196K 0.15% 223

Other funds holding SAGE

Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
BG
Bellevue Group Kuesnacht, Switzerland $4.2B AUM 54.85% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return
BC
Boxer Capital San Diego, California $2.04B AUM 108.39% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return

Quantamental Technologies's SAGE Position: Q2 2023 in Review

Quantamental Technologies sold out of Sage Therapeutics (SAGE) in Q2 2023, closing a stake of 5,653 shares — an estimated $237K sold.

Quantamental Technologies first reported a position in SAGE in Q2 2020 and held it in 3 quarters. The position peaked at $287K in Q3 2020. 225 funds tracked by Wall St. Rank hold SAGE as of Q2 2023.

  • Quantamental Technologies reported no remaining Sage Therapeutics position as of Q2 2023 after selling out during the quarter.
  • Quantamental Technologies sold 5,653 Sage Therapeutics shares in Q2 2023, an estimated $237K.
  • Quantamental Technologies first reported a position in Sage Therapeutics in Q2 2020 and held it in 3 quarters.
  • Quantamental Technologies's Sage Therapeutics position peaked at $287K in Q3 2020.
  • 225 funds tracked by Wall St. Rank held Sage Therapeutics as of Q2 2023.

Based on Quantamental Technologies's 13F filing for Q2 2023, filed 14 Aug 2023.